NASDAQ:PETS - PetMed Express Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $27.00
  • Forecasted Upside: 28.33 %
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$21.04
▲ +1.4 (7.13%)

This chart shows the closing price for PETS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PetMed Express Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PETS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PETS

Analyst Price Target is $27.00
▲ +28.33% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for PetMed Express in the last 3 months. The average price target is $27.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 28.33% upside from the last price of $21.04.

This chart shows the closing price for PETS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 polled investment analysts is to hold stock in PetMed Express. This rating has held steady since November 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/25/2022Morgan StanleyLower Price TargetUnderweight$25.00 ➝ $21.00High
1/20/2022SidotiUpgradeNeutral ➝ Buy$32.00High
11/18/2021Morgan StanleyInitiated CoverageUnderweight$25.00High
9/30/2021Jefferies Financial GroupInitiated CoverageHold$28.00Medium
6/3/2021SidotiDowngradeBuy ➝ Neutral$39.00High
3/5/2021SidotiUpgradeNeutral ➝ BuyHigh
1/27/2021SidotiDowngradeBuy ➝ NeutralHigh
8/19/2020SidotiUpgradeNeutral ➝ Buy$37.00 ➝ $41.00Medium
4/9/2020SidotiDowngradeBuy ➝ Neutral$31.00Low
3/12/2020SidotiUpgradeNeutral ➝ Buy$31.00Medium
2/24/2020SidotiDowngradeBuy ➝ Neutral$31.00High
1/2/2020SidotiReiterated RatingBuy$29.00Low
10/17/2019Craig HallumBoost Price TargetHold$15.00 ➝ $20.00Low
8/16/2019Craig HallumDowngradeBuy ➝ Hold$15.00High
1/23/2019Craig HallumLower Price TargetSell$25.00 ➝ $18.00High
7/9/2018Craig HallumReiterated RatingHold ➝ Sell$38.00 ➝ $32.00High
6/15/2018CL KingInitiated CoverageNeutralHigh
5/8/2018Craig HallumLower Price TargetHold$38.00Low
1/3/2018Northcoast ResearchSet Price TargetBuy$58.00High
10/27/2017Noble FinancialReiterated RatingHoldN/A
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00Low
8/24/2017SidotiUpgradeNeutral ➝ Buy$47.00High
8/21/2017Craig HallumReiterated RatingHold$43.00 ➝ $40.00High
7/26/2017Noble FinancialReiterated RatingHoldLow
7/24/2017Northcoast ResearchUpgradeNeutral ➝ Buy$54.00High
7/11/2017Craig HallumDowngradeBuy ➝ HoldHigh
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.71 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 3 very positive mentions
  • 14 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
2/5/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/7/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/6/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/6/2022
  • 5 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
6/5/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
PetMed Express logo
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Read More

Today's Range

Now: $21.04
Low: $19.18
High: $21.27

50 Day Range

MA: $21.34
Low: $19.64
High: $22.99

52 Week Range

Now: $21.04
Low: $19.08
High: $34.26

Volume

603,112 shs

Average Volume

412,889 shs

Market Capitalization

$441.63 million

P/E Ratio

20.24

Dividend Yield

6.11%

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of PetMed Express?

The following Wall Street sell-side analysts have issued reports on PetMed Express in the last year: Jefferies Financial Group Inc., Morgan Stanley, Sidoti, StockNews.com, and TheStreet.
View the latest analyst ratings for PETS.

What is the current price target for PetMed Express?

0 Wall Street analysts have set twelve-month price targets for PetMed Express in the last year. Their average twelve-month price target is $27.00, suggesting a possible upside of 28.3%.
View the latest price targets for PETS.

What is the current consensus analyst rating for PetMed Express?

PetMed Express currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PETS, but not buy more shares or sell existing shares.
View the latest ratings for PETS.

What other companies compete with PetMed Express?

How do I contact PetMed Express' investor relations team?

PetMed Express' physical mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company's listed phone number is (561) 526-4444 and its investor relations email address is [email protected] The official website for PetMed Express is www.1800petmeds.com. Learn More about contacing PetMed Express investor relations.